The Pharma Data

NOVEMBER 5, 2020

and Aavis Pharmaceuticals Inc. “We are pleased to announce the commercial launch of Hydroxychloroquine Sulfate tablets in the U.S.through our marketing partner,” stated Ashok Barot , Chairman, Aavis Pharmaceuticals. D/B/A Aavis Pharmaceuticals. About Jubilant Cadista Pharmaceuticals Inc. YARDLEY, Pa.

Marketing 40

Marketing Generic Pharmaceutical Contract Manufacturing Manufacturing 40

Pharmaceutical Technology

DECEMBER 22, 2022

Financing recognises companies and institutions that have raised significant capital during the research period whether it be through corporate finance, the capital markets or fund raising. The category includes any projects that demonstrate an innovative approach to the market.

Insulin 130

Insulin Production Development Genetics 130

XTalks

JUNE 8, 2022

Sandoz is a pioneering leader in generic pharmaceuticals and biosimilars, as Sandoz launched the world’s first biosimilar in Europe in 2006 and won the first biosimilar approval in the US in 2014. As a result, the company is currently embroiled in legal disputes over claims of creating a market monopoly. percent.

Generic Pharmaceutical 69

Generic Pharmaceutical Branding Production Medicine 69

Pharma in Brief

DECEMBER 3, 2023

The Regulations were meant to counterbalance the early-working exception by providing innovators with an enforcement tool to prevent patent infringement prior to generic or biosimilar market entry. Evolution of the Regulations Coming into force (1993–1997). Frequent amendments (1998–2016).

Regulation 52

Regulation Compliance Medicine Manufacturing 52

The Pharma Data

MAY 15, 2023

Before joining EMMI Group as CEO, he was a Member of the Executive Board and Head of the Marketing Department at Migros-Genossenschafts-Bund. He holds a Master degree in Marketing and Trade from the University of St. Our ambition is to be the world’s leading and most valued generics company. Gallen (HSG), Switzerland.

Sales 40

Sales Production Doctors Doctor 40

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33

Sales 98

Sales Manufacturing FDA Approval Life Science 98